透析患者机械瓣与生物瓣置换的16年多中心结局
该多中心回顾性研究纳入2000年至2016年7家医院312例透析患者,比较机械瓣(94例)与生物瓣(218例)置换的长期结局。结果显示两组5年和10年生存率无显著差异,但机械瓣组5年无瓣膜相关栓塞事件率显著更低。多因素分析显示糖尿病肾病、NYHA≥III级和二尖瓣置换是晚期死亡危险因素,瓣膜选择非危险因素。
要点
- 透析患者机械瓣与生物瓣置换的5年和10年生存率无显著差异。
- 机械瓣组5年无瓣膜相关栓塞事件率显著低于生物瓣组。
- 糖尿病肾病、NYHA≥III级和二尖瓣置换是晚期死亡的独立危险因素。
核心结论
- 瓣膜选择与透析患者晚期生存结局无关。
- 生物瓣在预防栓塞事件方面可能优于机械瓣,且不增加瓣膜相关再手术发生率。
研究设计与样本
- 回顾性多中心研究,纳入7家医院2000年4月至2016年4月间312例透析并接受瓣膜置换的患者。
- 机械瓣组94例(30.1%),生物瓣组218例(69.9%),平均随访3.4±3.6年。
主要发现
- 两组无瓣膜相关再手术或出血事件率相似。
临床怎么用
- 透析患者瓣膜选择需个体化,生物瓣可能减少栓塞事件且不增加再手术风险。
- 应重视糖尿病肾病、NYHA≥III级和二尖瓣置换等晚期死亡危险因素的管理。
局限性
- 回顾性研究设计。
- 平均随访时间较短(3.4±3.6年)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the long-term outcomes of heart valve replacement with mechanical prosthesis (MP) versus bioprosthesis (BP) in patients on dialysis. METHODS: A retrospective review was performed at 7 hospitals. Patients on dialysis who underwent valve replacement were included. Survival, reoperation, bleeding, and embolic events were compared across the MP and BP groups. RESULTS: Between April 2000 and April 2016, 312 patients on dialysis were enrolled in our study (MP: 94 patients [30.1%], BP: 218 patients [69.9%]). Mean follow-up was 3.4 ± 3.6 years. Five-year and 10-year survival rates were similar in both groups (MP: 57.4 ± 5.5% at 5 years and 46.3 ± 6.4% at 10 years, BP: 50.2 ± 4.1% at 5 years and 38.8 ± 4.5% at 10 years, P = .305). Multivariate Cox hazard analysis demonstrated that diabetic nephropathy (hazard ratio [HR], 1.90; 95% confidence interval [CI], 1.31-2.73, P < .001), New York Heart Association functional classification ≥III (HR, 2.16; 95% CI, 1.37-3.35, P = .001), and mitral valve replacement (HR, 2.36; 95% CI, 1.58-3.49, P < .001) were significant risk factors for late death. Valve selection was not a significant risk factor. Freedom from valve-related embolic event at 5 years was significantly lower in the MP group (MP: 88.3 ± 4.3% at 5 years, BP: 97.2 ± 1.6% at 5 years, P = .007). Freedom from valve-related reoperation or hemorrhagic events was similar across both groups. CONCLUSIONS: Valve selection was not associated with late survival outcomes in patients on dialysis. However, BP may have an advantage in preventing embolic events without increasing the incidence of valve-related reoperation when compared with MP.
引用
- Ikeno Y, Mukohara N, Fukumura Y, et al. Outcomes of valve replacement with mechanical prosthesis versus bioprosthesis in dialysis patients: A 16-year multicenter experience. J Thorac Cardiovasc Surg. 2018. PMID: 30660406. doi:10.1016/j.jtcvs.2018.11.089
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。